Browsing by Author "Abud-Mendoza, Carlos"

Now showing items 1-2 of 2

    • Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: Comparison ... 
      Yoo, Dae Hyun; Prodanovic, Nenad; Jaworski, Janusz; Miranda, Pedro; Ramiterre, Edgar; Lanzon, Allan; Baranauskaite, Asta; Wiland, Piotr; Abud-Mendoza, Carlos; Oparanov, Boycho; Smiyan, Svitlana; Kim, Houng; Lee, Sang Joon; Kim, Suyeon; Park, Won (BMJ Publishing Group, 2017)
      © 2017 Published by the BMJ Publishing Group Limited.Objectives To assess the efficacy and safety of switching from the infliximab reference product (RP; Remicade) to its biosimilar CT-P13 (Remsima, Inflectra) or continuing ...
    • Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 ... 
      Park, Won; Yoo, Dae Hyun; Miranda, Pedro; Brzosko, Marek; Wiland, Piotr; Gutierrez-Ureña, Sergio; Mikazane, Helena; Lee, Yeon Ah; Smiyan, Svitlana; Lim, Mie Jin; Kadinov, Vladimir; Abud-Mendoza, Carlos; Kim, Houng; Lee, Sang Joon; Bae, Yunju; Kim, Suyeon; Braun, Jürgen (BMJ Publishing Group, 2017)
      Objectives To investigate the efficacy and safety of switching from infliximab reference product (RP) to its biosimilar or maintaining biosimilar treatment in patients with ankylosing spondylitis (AS). Methods This open-label ...